The corporate boards of two of America's most influential companies will look different going forward. In separate press releases, both PepsiCo and Goldman Sachs announced the departure of director James J. Schiro, who will undergo treatment for a type of blood cancer called multiple myeloma.
A source familiar with PepsiCo's board told CNBC that it would not fill the role vacated by Schiro. Instead, the company plans to move forward with 12 board members, which is consistent with the firm's bylaws.
Goldman Sachs announced that Adebayo Ogunlesi, a former Credit Suisse investment banker and current private equity executive, would assume the role of lead director. Ogunlesi has been a member of the board since 2012.